Insiders · Profile

DENYES NANCY

General Counsel at aTYR PHARMA. Filing since 17 May 2019. CIK 0001640869

Company

Date

Role

Action

Amount

Of holding

4 Feb 2026

General Counsel

Sold at will

1,118

$1.09K

3.3%

4 Feb 2025

General Counsel

Sold at will

899

$3.40K

3.3%

5 Jun 2024

General Counsel

Bought

5,000

$9.28K

29.0%

20 May 2020

General Counsel

Sold, plan not stated

322

$1.17K

10.5%

17 May 2019

General Counsel

Sold, plan not stated

4,651

$2.09K

15.5%

5 decisions on file.